The role of insulin resistance in the relationship between uric acid and the severity of coronary artery disease: evidence from real-world data
Open Access
- 6 October 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1660317
Abstract
Background: The link between uric acid (UA) and cardiovascular diseases is debated, with insulin resistance possibly affecting this relationship. The triglyceride-glucose (TyG) index is a recognized marker for insulin resistance. However, the combined effect of different levels of UA and TyG on the severity of coronary artery disease (CAD) remains unclear.Methods: A cohort of 1,835 patients with newly diagnosed CAD was divided into single-vessel (743 patients) and multi-vessel (1,092 patients) CAD groups. The study utilized logistic regression, restricted cubic spline (RCS), and extreme gradient boosting (XGBoost) models to explore the associations between UA, TyG, and multi-vessel CAD. Interaction analysis assessed potential additive and multiplicative interactions. A mediation analysis was performed to assess the indirect effects of TyG and UA on the severity of CAD.Results: The TyG > 9.33 and non-HUA group is linked to a higher risk of multi-vessel CAD (OR 1.41, 95% CI 1.08–1.85), while the TyG ≤ 9.33 and HUA group shows no significant association (OR 1.08, 95% CI 0.76–1.53). The feature importance analysis, using the XGBoost model, demonstrated that TyG has a higher predictive value for multi-vessel CAD. No nonlinear correlations were observed for RCS. No notable additive or multiplicative interactions were detected between TyG and UA. Mediation analysis revealed that TyG significantly mediated the relationship between UA and multi-vessel CAD, with a proportion mediated of 18.89% (p = 0.026). In contrast, UA did not significantly mediate the TyG–CAD relationship (p = 0.082).Conclusion: The TyG index correlated more strongly with multi-vessel CAD compared to UA. Hyperuricemia correlated with multi-vessel CAD exclusively at elevated TyG levels, with TyG mediating the link between uric acid and CAD severity.Keywords
This publication has 35 references indexed in Scilit:
- Hyperuricemia and its related diseases: mechanisms and advances in therapySignal Transduction and Targeted Therapy, 2024
- Causal relationship between serum uric acid and cardiovascular disease: A Mendelian randomization studyIJC Heart & Vasculature, 2024
- Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Serum uric acid and left ventricular mass index independently predict cardiovascular mortality: The uric acid right for heart health (URRAH) projectEuropean Journal of Internal Medicine, 2023
- Uric acid and cardiovascular diseaseClinica Chimica Acta, 2018
- Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart StudyScientific Reports, 2018
- Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular MechanismsCanadian Journal of Cardiology, 2018
- Uric acid in metabolic syndrome: From an innocent bystander to a central playerEuropean Journal of Internal Medicine, 2016
- High uric acid directly inhibits insulin signalling and induces insulin resistanceBiochemical and Biophysical Research Communications, 2014
- Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes StudyDiabetologia, 2010